A detailed history of Rock Springs Capital Management LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rock Springs Capital Management LP holds 550,000 shares of EW stock, worth $36 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
550,000
Previous 647,300 15.03%
Holding current value
$36 Million
Previous $61.9 Million 17.87%
% of portfolio
1.58%
Previous 1.62%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $8.2 Million - $9.18 Million
-97,300 Reduced 15.03%
550,000 $50.8 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $96,992 - $130,732
1,400 Added 0.22%
647,300 $44.8 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $1.02 Million - $1.3 Million
14,900 Added 2.36%
645,900 $48.2 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $2.39 Million - $3.11 Million
29,000 Added 4.82%
631,000 $52.1 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $475,750 - $705,485
5,500 Added 0.92%
602,000 $57.2 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $1.48 Million - $1.86 Million
14,500 Added 2.49%
596,500 $70.2 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $22.3 Million - $29.9 Million
388,000 Added 200.0%
582,000 $40.2 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $550,305 - $850,500
10,500 Added 5.72%
194,000 $36.6 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $162,435 - $199,290
3,500 Added 1.94%
183,500 $28.1 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $685,500 - $870,450
15,000 Added 9.09%
180,000 $31.3 Million
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $1.06 Million - $1.28 Million
-25,001 Reduced 13.16%
165,000 $24 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $6.9 Million - $7.38 Million
190,001
190,001 $20.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.